A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove safe and effective for chronic pain. View original article Contributor: Daniel Gilbert, David Ovalle
By 2060, new dementia cases per year could double to one million because of the growing population of older Americans, a study predicts. View original article Contributor: Pam Belluck
Outbreaks among the unvaccinated are a predictable consequence of falling immunization rates. But even vaccinated adults may be vulnerable to some illnesses. View original article Contributor: Apoorva Mandavilli
In its original form, the virus survives in just two countries. But a type linked to an oral vaccine used in other nations has already turned up in the West. View original article Contributor: Apoorva Mandavilli
Xavier Becerra, who has led the Department of Health and Human Services, says federal agencies are outmatched in a world of “instantaneous information and disinformation.” View original article Contributor: Dan Diamond
Understanding a child’s asthma type can help target treatment, but pinpointing it has relied on an invasive procedure that can be difficult to perform on a child. View original article Contributor: Erin Blakemore
8 things to know, including the indictment of an ‘alternative medicine’ clinic operator and yard signs converted to energy The Business Journals >View original article Contributor:
Matthew Livelsberger’s dramatic death at the Trump hotel in Las Vegas has spotlighted the Pentagon’s efforts to screen for and treat invisible injuries. View original article Contributor: Alex Horton
Why More Americans Are Turning to Holistic Health Care RealClearHealth >View original article Contributor:
Norovirus is surging across the U.S., with case numbers higher now than they’ve been at the same time in more than a decade, according to the U.S. Centers for Disease Control and Prevention (CDC). There is no antiviral treatment for the miserable but thankfully short-lived illness, and no vaccine—yet. But scientists at Moderna are in … Read more